BioCatch culminates first round of tech funding at USD 30 million
Category: #world  By Dhananjay Punekar  Date: 2018-03-13
  • share
  • Twitter
  • Google Plus
  • Facebook
  • LinkedIn

BioCatch culminates first round of tech funding at USD 30 million

BioCatch Limited, one of the pivotal players of the behavioral biometrics technology sector, has recently closed at USD 30 million in growth funding. Other investment groups such as CreditEase, American Express Ventures, Kreos Capital, Maverick Ventures, and NexStar Partners have also participated in the first round of the funding. Reportedly, the cybersecurity system of the startup firm – its patented “behavioral biometric authentication and threat detection” technology enables banks and high-transaction companies to stop online fraud even before it takes place.

The CEO of BioCatch has stated that the fund raising has come in the wake of increasing awareness of the behavioral biometric system among the financial institutions along with the expanding consumer base of the firm. He further added that the goal of BioCatch is to expand its business across P2P payment, insurance, healthcare, cryptocurrency, and government sectors.

BioCatch has also been positively popularizing its patented IP portfolio, with over fifty-six patents to its name. A key official of the firm, in this regard, has stated that one of the firm’s granted patents, which helps in identification of the mobile user, encompasses the physiological factors such as eye & hand co-ordination, palm size, hand tremor, and size of the hand when pressed. He further declared that the physiological features of the user are integrated with their behaviors such as utility preferences & equipment interacting patterns to identify the authenticity of what the customer proclaims.

For the record, the firm’s technology accumulates and examines over 500 cognitive norms, such as a unique way of an individual wiggling the mouse after the disappearance of the cursor or the way a person holds the smartphone. After analyzing the parameters based on the behavioral traits of the person, BioCatch generates a unique profile of an individual to authenticate the user identity.

Industry experts claim that this new tool will effectively work against phishing or bot attacks, thereby reducing the incidences of fraudulent acts.



About Author

Dhananjay Punekar

Email: dhananjay.p@news.marketsizeforecasters.com   

Dhananjay Punekar

Dhananjay Punekar presently develops content for a slew of portals, including Market Size Forecasters and Algosonline. A post graduate in mathematics and business administration, he worked in Infosys BPO Limited prior to switching his professional genre. As a content wr...

Read More

More News By Dhananjay Punekar

AstraZeneca gets import & marketing approval for Durvalumab in India
AstraZeneca gets import & marketing approval for Durvalumab in India
By Dhananjay Punekar

AstraZeneca Pharma India, a division of pharma & biopharma giant AstraZeneca plc, has received a green signal from the Indian drug regulating agency DCGI (Drug Controller General of India) for its drug Durvalumab c...

BP exits deal with Woolworths, retail firm looks out for alternatives
BP exits deal with Woolworths, retail firm looks out for alternatives
By Dhananjay Punekar

BP Plc, a UK based oil & gas firm, has decided to terminate its USD 1.8 billion acquisition deal with Australian retail giant Woolworths. For the record, the British oil & gas company had signed a pact to purch...

Sarepta obtains positive results on DMD therapy, shares skyrocket 50%
Sarepta obtains positive results on DMD therapy, shares skyrocket 50%
By Dhananjay Punekar

The shares of Sarepta Therapeutics Inc., a medical research & drug development firm, climbed up by 50% after the firm released initial results derived from clinical treatment on patients suffering from Duchenne mus...